Material Agreements

AQUABOUNTY TECHNOLOGIES INC entered into Loan and Security agreement with JMB Capital Partners Lending, LLC valued at $10 million (effective 2024-04-18).

“Inc. (the “Company”), AquaBounty Farms, Inc. (the “Parent”), which is a subsidiary of the Company, AquaBounty Farms Indiana LLC (“ABFI”), a subsidiary of the Parent, and AquaBounty Farms Ohio LLC (“ABFO” and, together with the Company, the Parent and ABFI, the “Borrowers”), a subsidiary of the Parent, entered into a Loan and Security agreement (the “Loan Agreement”) with JMB Capital Partners Lending, LLC (the “Lender”) to fund working capital of the Borrowers through a secured term loan of up to $10 million (the “Loan”) that matures on July 31, 2024”

CNH Industrial N.V. terminated Five-Year Multicurrency Revolving Credit Agreement with Citibank Europe PLC, UK Branch (as facility agent) valued at $4 billion (effective 2024-04-19).

“On April 19, 2024, the Company terminated its five-year multicurrency revolving credit agreement, dated March 18, 2021, as amended and restated on December 10, 2021, among CNH Industrial Finance S.p.A., CNH Industrial Finance Europe S.A., and CNH Industrial Finance North America, Inc. as borrowers, the Company as guarantor, certain banks as lenders and Citibank Europe PLC, UK Branch as facility agent (the “Old Credit Agreement”). The Old Credit Agreement established an unsecured, committed revolving credit facility in an aggregate principal amount equal to $4 billion, with two extension options of 1-year each. The Old Credit Agreement was terminated in connection with the entry into the Credit Agreement described in Item 1.01 above.”

CNH Industrial N.V. entered into Multicurrency Revolving Credit Agreement with Citibank Europe Plc, UK Branch (as facility agent) valued at €3.25 billion (effective 2024-04-19).

“On April 19, 2024, CNH Industrial N.V. (the “Company” or “CNH”) entered into a multicurrency revolving credit agreement with Citibank Europe Plc, UK Branch as facility agent, and the other lenders named therein (the “Credit Agreement”). The Credit Agreement provides for an unsecured, committed revolving credit facility in an aggregate principal amount equal to €3.25 billion. The Company may elect to increase the total commitments under the Credit Facility by up to an additional €500 million. The proceeds of the loans under the Credit Agreement may be used for general corporate and working capital purposes, including without limitation the refinancing of existing indebtedness of the CNH group. The Credit Facility will mature, and all outstanding loans will become due and payable, on April 19, 2029, or such later date as may be extended pursuant to the two extension options of 1-year each which are available to the Company on the terms set forth in the Credit Agreement. The Credit Agreem”

ClearSign Technologies Corp entered into Securities Purchase Agreement with an accredited investor (effective 2024-04-19).

“On April 19, 2024, the Company entered into a securities purchase agreement (the “Securities Purchase Agreement”) with an accredited investor (“Private Purchaser”) whereby the Company will issue, in a private placement (the “Concurrent Private Offering”) to be completed concurrently with the completion of the Public Offering, an aggregate of (i) 5,405,405 shares of Common Stock (the “Private Shares”), and (ii) redeemable warrants (the “Private Warrants”) to purchase up to an aggregate of 8,108,108 shares of the Company’s common stock”

ClearSign Technologies Corp entered into Underwriting Agreement with Public Ventures, LLC valued at aggregate gross proceeds of $4,251,099 (effective 2024-04-19).

“On April 19, 2024, ClearSign Technologies Corporation, a Delaware corporation (the “Company”), entered into an underwriting agreement (the “Underwriting Agreement”) with Public Ventures, LLC (“Public Ventures”), as underwriter, relating to the offering, issuance and sale of an aggregate of (i) 4,620,760 shares of the Company’s common stock”

INVO Fertility, Inc. terminated a lease with Brown Fertility Associates PA (effective 2024-04-19).

“On April 19, 2024, INVO Centers LLC ("INVO Centers"), a wholly owned subsidiary of INVO Bioscience, Inc. (the "Company"), completed the assignment to Brown Fertility Associates PA ("Brown Fertility") of its lease with 4602 North Armenia Ave, LLC (the "Landlord"), for the property located at 4602 North Armenia Avenue, Suite 200, Tampa, LLC (the "Premises").”

NS Wind Down Co., Inc. terminated Patient Square Asset Purchase Agreement with an affiliate of Patient Square Capital (effective 2024-04-17).

“On April 17, 2024, as a result of the outcome of the Auction, the Patient Square Asset Purchase Agreement was terminated.”

NS Wind Down Co., Inc. entered into Bruker Asset Purchase Agreement with Bruker Corporation valued at $392,555,000 (effective 2024-04-17).

“On April 17, 2024, the Company and Bruker entered into an Asset Purchase Agreement (the “Bruker Asset Purchase Agreement”) to sell substantially all of the assets of the Company and its subsidiaries (the “Business”) for a cash purchase price of $392,555,000 (the “Purchase Price”) along with Bruker’s assumption of certain liabilities of the Business (including liabilities related to all outstanding intellectual property litigation).”

QUAINT OAK BANCORP, INC. entered into Stock Purchase Agreement with Areti Bank International Inc. valued at $1,448,195 aggregate proceeds for 128,500 shares at $11.27 per share (effective 2024-04-19).

“On April 19, 2024, Quaint Oak Bancorp, Inc., a Pennsylvania corporation and the holding company for Quaint Oak Bank (the "Company"), entered into a Stock Purchase Agreement (the “Purchase Agreement”) with Areti Bank International Inc., an international banking entity incorporated in the Commonwealth of Puerto Rico (“Areti Bank”).”

Kartoon Studios, Inc. entered into Placement Agreement with EF Hutton LLC (effective 2024-04-18).

“On April 18, 2024, the Company also entered into a placement agent agreement (the “Placement Agreement”) with EF Hutton LLC, as the placement agent (the “Placement Agent”), in connection with the Offering.”

Kartoon Studios, Inc. entered into Purchase Agreement with certain institutional investors (effective 2024-04-18).

“On April 18, 2024, Kartoon Studios, Inc. (the “Company”) entered into a securities purchase agreement (the “Purchase Agreement”) pursuant to which the Company agreed to issue and sell directly to certain institutional investors up to 7,000,000 shares (the “Shares”) of common stock”

CARMAX AUTO FUNDING LLC entered into Underwriting Agreement with MUFG Securities Americas Inc., as representative of the several underwriters named therein valued at $1,600,000,000 aggregate principal balance (effective 2024-04-17).

“On April 17, 2024, CarMax Business Services, LLC (“CarMax Business Services”) and CarMax Auto Funding LLC (the “Depositor”) entered into an Underwriting Agreement with MUFG Securities Americas Inc., as representative of the several underwriters named therein (collectively, the “Underwriters”), whereby each of the Underwriters has severally agreed to purchase $1,600,000,000 aggregate principal balance of various classes of Asset-backed Notes to be issued by CarMax Auto Owner Trust 2024-2”

BIO-PATH HOLDINGS, INC. entered into Engagement Letter with H.C. Wainwright & Co., LLC (effective 2024-03-22).

“On March 22, 2024, the Company entered into an engagement letter (the “Engagement Letter”) with H.C. Wainwright & Co., LLC (the “Placement Agent”).”

BIO-PATH HOLDINGS, INC. entered into Purchase Agreement with certain institutional investors valued at approximately $1.2 million (effective 2024-04-18).

“On April 18, 2024, Bio-Path Holdings, Inc. (the “Company”) entered into a securities purchase agreement (the “Purchase Agreement”) with certain institutional investors, pursuant to which the Company agreed to sell, in a registered direct offering (the “Registered Direct Offering”), an aggregate of 375,000 shares (the “Shares”) of its common stock, par value $0.001 per share (“Common Stock”), for a purchase price per Share of $3.225 and gross proceeds of approximately $1.2 million.”

CUMULUS MEDIA INC entered into Transaction Support Agreement with Ad-Hoc Group valued at 1% paid-in-kind fee (effective 2024-04-18).

“On April 18, 2024, Cumulus Media Inc. (the “Company”) announced that its wholly-owned subsidiary, Cumulus Media New Holdings Inc. (the “Issuer”), entered into a Transaction Support Agreement (the “Transaction Support Agreement”) with a certain group of the Issuer’s Old Term Loan (as defined therein) lenders and holders of Old Notes”

ABERDEEN INDIA FUND, INC. entered into Dealer Manager Agreement with UBS Securities LLC (effective 2024-04-18).

“On April 18, 2024, The India Fund, Inc. (NYSE: IFN) (the “Fund”) entered into a dealer manager agreement (the “Dealer Manager Agreement”) by and among the Fund, abrdn Asia Limited and UBS Securities LLC”

ProPhase Labs, Inc. entered into Standstill Agreement with ThinkEquity LLC (effective 2024-04-18).

“On April 18, 2024, ProPhase Labs, Inc. (the “Company”) entered into a standstill agreement with ThinkEquity LLC (the “Sales Agent”) (such agreement, the “Standstill Agreement”).”

CHS INC entered into Note Purchase Agreement with the accredited investors signatory thereto (collectively, the "Purchasers") valued at $700,000,000 (effective 2024-04-18).

“On April 18, 2024, CHS Inc. (the “Company”) entered into a Note Purchase Agreement (the “Note Purchase Agreement”) with the accredited investors signatory thereto (collectively, the “Purchasers”), pursuant to which the Company will issue and sell, in a private placement, its, (i) Series DD Notes in the aggregate principal amount of $150,000,000 with a maturity date of July 16, 2032 (the “Series DD Notes”), (ii) Series EE Notes in the aggregate principal amount of $150,000,000 with a maturity date of July 16, 2034 (the “Series EE Notes”), (iii) Series FF Notes in the aggregate principal amount of $150,000,000 with a maturity date of July 16, 2037 (the “Series FF Notes”) and (iv) Series GG Notes in the aggregate principal amount of $250,000,000 with a maturity date of July 16, 2039 (the “Series GG Notes” together with the Series DD Notes, the Series EE Notes and the Series FF Notes, the “Notes”).”

Sanara MedTech Inc. entered into Loan Agreement with CRG Servicing LLC valued at up to $55.0 million (effective 2024-04-17).

“Sanara MedTech Inc. (the “Company”) entered into a Term Loan Agreement (the “Loan Agreement”), by and among the Company, as borrower, the subsidiary guarantors party thereto from time to time (collectively, the “Guarantors”), CRG Servicing LLC, as administrative agent and collateral agent (the “Agent”), and the lenders party thereto from time to time, providing for a senior secured term loan of up to $55.0 million (the “Loan”).”

SunOpta Inc. entered into Amending Agreement with Oaktree Organics, L.P., Oaktree Huntington Investment Fund II, L.P., OCM SunOpta Trustee LLC valued at Elimination of dividend rights attached to shares of Series B-1 Preferred Stock of SunOpta Foods eff (effective 2024-04-17).

“On April 17, 2024, SunOpta Inc. (the "Company"), SunOpta Foods Inc. ("SunOpta Foods"), a wholly-owned subsidiary of the Company, Oaktree Organics, L.P., Oaktree Huntington Investment Fund II, L.P. (together with Oaktree Organics, L.P, the "Investors"), and OCM SunOpta Trustee LLC (the "Trustee"), entered into an Amending Agreement (the "Amending Agreement") related to the elimination of the dividend rights attached to shares of Series B-1 Preferred Stock of SunOpta Foods effective from and after December 31, 2023, including amending the terms of (i) the Amended and Restated Investor Rights Agreement, dated April 24, 2020, among the Company, SunOpta Foods and the Investors, (ii) the Exchange and Support Agreement, dated April 24, 2020, among the Company, SunOpta Foods and the Investors, and (iii) the Voting Trust Agreement, dated April 24, 2020, among the Company, SunOpta Foods, the Investors and the Trustee”

PHX MINERALS INC. amended Sixth Amendment with Independent Bank (effective 2024-04-18).

“On April 18, 2024, PHX Minerals Inc., a Delaware corporation (the “Company”), entered into a Sixth Amendment (the “Sixth Amendment”) to Credit Agreement dated as of September 1, 2021 (as amended, the “Credit Agreement”), by and among the Company, the lenders party thereto, and Independent Bank, as Administrative Agent and L/C Issuer.”

VSEE HEALTH, INC. amended Extension Letter Agreement with an institutional and accredited investor (effective 2024-04-17).

“On April 17, 2024, the Company and the investor entered into a letter agreement (the “Extension Letter Agreement”), which amended the maturity date of the Extension Note to June 30, 2024 and clarified certain definitions and transaction terms in both the Extension Purchase Agreement and the Extension Note”

VSEE HEALTH, INC. amended Bridge Letter Agreement with the Bridge Investor (effective 2024-04-17).

“On April 17, 2024, the Company, VSee, and iDoc entered into a letter agreement with the Bridge Investor (the “Bridge Letter Agreement”), which amended the date with respect to the termination or closing of the business combination referenced in the Bridge Notes from March 31, 2024 to June 30, 2024”

VSEE HEALTH, INC. amended Second Amendment with Digital Health Acquisition Corp., DHAC Merger Sub I, Inc., DHAC Merger Sub II, Inc., VSee Lab, Inc., iDoc Virtual Telehealth Solutions, Inc. (effective 2024-04-17).

“On April 17, 2024, the Parties entered into a Second Amendment (the “Second Amendment”) to the Business Combination Agreement, pursuant to which the termination date in the Business Combination Agreement was amended from March 31, 2024 to June 30, 2024”

VSEE HEALTH, INC. entered into Third Amended and Restated Business Combination Agreement with Digital Health Acquisition Corp., DHAC Merger Sub I, Inc., DHAC Merger Sub II, Inc., VSee Lab, Inc., iDoc Virtual Telehealth Solutions, Inc. (effective 2023-11-21).

“Digital Health Acquisition Corp. (“DHAC” or the “Company”), DHAC Merger Sub I, Inc., a Delaware corporation and a wholly owned subsidiary of DHAC (“Merger Sub I”), DHAC Merger Sub II, Inc., a Texas corporation and a wholly owned subsidiary of DHAC (“Merger Sub II” and together with Merger Sub I, the “Merger Subs”), VSee Lab, Inc., a Delaware corporation (“VSee”), and iDoc Virtual Telehealth Solutions, Inc., a Texas corporation (“iDoc” and together with DHAC, Merger Sub I, Merger Sub II, VSee and iDoc, the “Parties”), entered into a Third Amended and Restated Business Combination Agreement on November 21, 2023”

Snap One Holdings Corp. entered into Agreement and Plan of Merger with Resideo Technologies, Inc. valued at $10.75 per share (effective 2024-04-14).

“On April 14, 2024, Snap One Holdings Corp., a Delaware corporation (“Snap One”), entered into an Agreement and Plan of Merger (the “Merger Agreement”), with Resideo Technologies, Inc., a Delaware corporation (“Resideo”), and Pop Acquisition Inc., a Delaware corporation and a wholly owned subsidiary of Resideo (“Merger Sub”), pursuant to which, subject to the terms and conditions of the Merger Agreement, Merger Sub will merge with and into Snap One, with Snap One continuing as the surviving corporation (the “Surviving Corporation”) and a wholly owned subsidiary of Resideo (the “Merger”).”

Calidi Biotherapeutics, Inc. amended Amendment to Convertible Note and Settlement Agreement with an investor valued at $1.5 million convertible note (effective 2024-04-14).

“On April 14, 2024, the Company amended the Note to provide that if the holder thereof participates in a registered public offering, under the same terms and conditions as other investors, in the amount equal to the principal amount of the Note, the proceeds from the sale of securities to the promissory noteholder would be used to pay off the Note.”

Generation Asia I Acquisition Ltd amended IMTA Amendment with Continental Stock Transfer & Trust Company valued at $35,000 (effective 2024-04-16).

“by depositing into the trust account an amount equal to $35,000 for each one-month extension of the date by which the Company has to consummate a business combination effective immediately, as described in more detail in the definitive proxy statement on Form DEF 14A as filed with the SEC on March 29, 2024. Following such approval by the Company’s stockholders, the Company and CST entered into the IMTA Amendment on April 16, 2024.”

Verizon ABS II LLC entered into Underwriting Agreement with Wells Fargo Securities, LLC, Mizuho Securities USA LLC, RBC Capital Markets, LLC and SMBC Nikko Securities America, Inc. (effective 2024-04-16).

“On April 16, 2024, Verizon Master Trust (the “ Trust ”), a Delaware statutory trust, and Cellco Partnership d/b/a Verizon Wireless (“ Cellco ”) entered into an Underwriting Agreement (the “ Underwriting Agreement ”) with of Wells Fargo Securities, LLC, Mizuho Securities USA LLC, RBC Capital Markets, LLC and SMBC Nikko Securities America, Inc., acting on behalf of themselves and as representatives of the several underwriters named therein, for the sale of certain notes of Series 2024-3.”

Terran Orbital Corp amended Amended and Restated Rights Agreement with Continental Stock Transfer & Trust Company (effective 2024-04-18).

“On April 18, 2024, Terran Orbital Corporation (the “Company”) entered into an Amended and Restated Rights Agreement (the “Amended Rights Agreement”), which amends and restates the Rights Agreement dated as of March 4, 2024 (the “Rights Agreement”), by and between the Company and Continental Stock Transfer & Trust Company, as rights agent.”

Serve Robotics Inc. /DE/ entered into Underwriting Agreement with Aegis Capital Corp. valued at $4.00 per share (effective 2024-04-17).

“On April 17, 2024, Serve Robotics Inc. (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with Aegis Capital Corp. (“Aegis”), as the representative of the several underwriters named in Schedule I thereto (collectively, the “Underwriters”), in connection with the public offering of 10,000,000 shares of the Company’s common stock, par value $0.0001 per share (the “Common Stock”), at a public offering price of $4.00 per share (the “Offering”).”

Serve Robotics Inc. /DE/ entered into Underwriting Agreement with Aegis Capital Corp., as the representative of the several underwriters valued at 10,000,000 shares of the Company’s common stock, par value $0.0001 per share, at a public offering p (effective 2024-04-17).

“On April 17, 2024, Serve Robotics Inc. (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with Aegis Capital Corp. (“Aegis”), as the representative of the several underwriters named in Schedule I thereto (collectively, the “Underwriters”), in connection with the public offering of 10,000,000 shares of the Company’s common stock, par value $0.0001 per share (the “Common Stock”), at a public offering price of $4.00 per share (the “Offering”).”

Motorsport Games Inc. entered into New BTCC License Agreement with BARC (TOCA) LIMITED valued at Annual royalty of 50% of Adjusted Gross Annual Sales of downloadable Products; term through December (effective 2024-04-12).

“Agreement”) with BARC (TOCA) LIMITED (“TOCA”). The Agreement resolved any and all disputes between the Company and TOCA with respect to the termination of the License agreement, dated May 29, 2020, between”

Motorsport Games Inc. entered into Settlement Agreement with BARC (TOCA) LIMITED valued at One-time payment of $225,000, forgiveness of all royalties and sums (effective 2024-04-12).

“On April 12, 2024, Motorsport Games Inc., a Delaware corporation (the "Company"), entered into a Settlement Agreement (the "Agreement") with BARC (TOCA) LIMITED ("TOCA").”

Mediaco Holding Inc. entered into Asset Purchase Agreement with Estrella Broadcasting, Inc., SLF LBI Aggregator, LLC (effective 2024-04-17).

“MediaCo Holding Inc., an Indiana corporation (“ MediaCo ”), and its wholly-owned subsidiary MediaCo Operations LLC, a Delaware limited liability company (“ Purchaser ”), entered into an asset purchase agreement (the “ Asset Purchase Agreement ”) with Estrella Broadcasting, Inc., a Delaware corporation (“ Estrella ”), and SLF LBI Aggregator, LLC, a Delaware limited liability company (“ Aggregator ”) and affiliate of HPS Investment Partners, LLC (“ HPS ”), pursuant to which Purchaser purchased substantially all of the assets of Estrella”

Odyssey Semiconductor Technologies, Inc. entered into Promissory Note with Nina and John Edmunds 1998 Family Trust dated January 27, 1998 valued at $190,000 (effective 2024-04-15).

“On April 15, 2024, Odyssey Semiconductor Technologies, Inc. (the “Company”) issued a secured convertible promissory note in the amount of $190,000 (the “Promissory Note”), to the Nina and John Edmunds 1998 Family Trust dated January 27, 1998 (the “Edmunds Trust”), of which the Company’s Chairman, John Edmunds, is the trustee.”

Advantage Solutions Inc. amended Third Amendment with Bank of America, N.A. (effective 2024-04-17).

“On April 17, 2024 (the “ Third Amendment Effective Date ”), Advantage Sales & Marketing Inc. (the “ Borrower ”), an indirect wholly-owned subsidiary of Advantage Solutions Inc. (the “ Company ”), together with Karman Intermediate Corp., a Delaware corporation (“ Holdings ”) and certain of the Borrower’s subsidiaries, entered into Amendment No. 3 to the First Lien Credit Agreement (the “ Third Amendment ”), which amends the First Lien Credit Agreement, dated as of October 28, 2020”

Augmedix, Inc. amended Amendment 1 to Statement of Work No. 3 with Sutter Health (effective 2024-04-15).

“On the Effective Date, the Company also entered into Amendment 1 to Statement of Work No. 3 (the “ SOW Amendment ”) with the Customer, pursuant to the MSA, as amended.”

Augmedix, Inc. amended Tenth Amendment to the Master Services Agreement with Sutter Health (effective 2024-04-15).

“On April 15, 2024 (the “ Effective Date ”), Augmedix Operating Corp., f/k/a Augmedix, Inc., a Delaware corporation (the “ Company ”), entered into the Tenth Amendment to the Master Services Agreement (the “ Tenth Amendment ”) with Sutter Health, a California nonprofit public benefit corporation (the “ Customer ”).”

Triller Group Inc. entered into Agreement and Plan of Merger with AGBA Group Holding Limited (effective 2024-04-16).

“On April 16, 2024, AGBA Group Holding Limited, a British Virgin Islands business company (“ AGBA ” or “ Parent ”), entered into that certain Agreement and Plan of Merger (as may be amended, supplemented or otherwise modified from time to time, the “ Merger Agreement ”), by and between AGBA, its wholly owned subsidiary AGBA Social Inc. (“ Merger Sub ”), Triller Corp., a Delaware corporation (“ Triller ” or the “ Company ”) and Bobby Sarnevesht, solely as representative of the Triller stockholders.”

Utz Brands, Inc. amended First Lien Credit Agreement valued at $630 million (effective 2024-04-17).

“Pursuant to the Refinancing Facility, the Borrower refinanced, in full, outstanding term loans having a principal amount of $630 million as of the Refinancing Date.”

Longeveron Inc. entered into Inducement Letter Agreements with certain holders valued at approximately $6.2 million (effective 2024-04-16).

“On April 16, 2024, Longeveron Inc., a Delaware corporation (the “Company”), entered into inducement letter agreements (the “Inducement Letter Agreements”) with certain holders (the “Holders”) of its existing (i) Series A warrants to purchase up to an aggregate of 242,425 shares of the Company’s Class A common stock”

Cosmos Group Holdings Inc. entered into Bought and Sold Agreement with Guangzhou Huangting Meishuguan valued at HKD$ 134,280,000 (approximately USD$17.13 million) (effective 2024-04-16).

“On April 16, 2024, Grand Town Development Limited (“Grand Town”), a fully owned subsidiary of Cosmos Group Holdings Inc. (“COSG”, the “Company”), And Guangzhou Huangting Meishuguan (“Seller”) Entered into four Bought and Sold Agreements, whereby Seller has agreed to sell Grand Town four pieces of collectible items at HKD$ 134,280,000 (approximately USD$17.13 million).”

Korro Bio, Inc. entered into Subscription Agreement with a number of institutional accredited investors valued at approximately $70.0 million (effective 2024-04-17).

“On April 17, 2024, we entered into a subscription agreement with a number of institutional accredited investors pursuant to which we agreed to sell and issue in a private placement”

Datavault AI Inc. entered into Placement Agency Agreement with Maxim Group LLC valued at aggregate fee equal to 6.0% of the gross proceeds raised in the Offerings (effective 2024-04-17).

“on April 17, 2024, the Company entered into a placement agency agreement (the “Placement Agency Agreement”) with Maxim Group LLC (the “Placement Agent”)”

Datavault AI Inc. entered into Purchase Agreement with certain purchasers valued at aggregate gross proceeds of approximately $750,000 (effective 2024-04-17).

“On April 17, 2024, WiSA Technologies, Inc., a Delaware corporation (the “Company”), entered into a securities purchase agreement (the “Purchase Agreement”) with certain purchasers”

ATLANTIC INTERNATIONAL CORP. amended Amendment No. 6 to the Agreement and Plan of Reorganization with SeqLL, Inc., Atlantic Acquisition Corp, Atlantic Merger LLC, Lyneer Investments, LLC, IDC Technologies, Inc., and Lyneer Management Holdings LLC valued at Amendment modifies Lyneer Stock Consideration to be 100% issuable to IDC and adjusts Cash Considerat (effective 2024-04-15).

“On April 15, 2024, the Company entered into Amendment No. 6 to the Agreement and Plan of Reorganization (the “Amendment”) with the other parties thereto.”

Intra-Cellular Therapies, Inc. entered into Underwriting Agreement with J.P. Morgan Securities LLC, Leerink Partners LLC, BofA Securities, Inc., Morgan Stanley & Co. LLC and RBC Capital Markets, LLC, as representatives of the several underwriters named therein valued at approximately $472.1 million (effective 2024-04-17).

“On April 17, 2024, Intra-Cellular Therapies, Inc. (the “ Company ”) entered into an underwriting agreement (the “ Underwriting Agreement ”) with J.P. Morgan Securities LLC, Leerink Partners LLC, BofA Securities, Inc., Morgan Stanley & Co. LLC and RBC Capital Markets, LLC, as representatives of the several underwriters named therein (collectively, the “ Underwriters ”), relating to an underwritten public offering of 6,849,316 shares (the “ Underwritten Shares ”) of the Company’s common stock”

Diamondback Energy, Inc. entered into Second Supplemental Indenture with Computershare Trust Company, National Association valued at $850,000,000 aggregate principal amount of its 5.200% Senior Notes due 2027, $850,000,000 aggregate (effective 2024-04-18).

“the Second Supplemental Indenture, dated as of April 18, 2024 (the “Second Supplemental Indenture” and, together with the Base Indenture, the “Indenture”), among the Company, as the issuer, Diamondback E&P LLC, as the subsidiary guarantor (“E&P”), and the Trustee, setting forth specific terms applicable to the Notes.”